z-logo
Premium
The pharmacokinetic and bactericidal characteristics of oral cefixime
Author(s) -
Brittain David C,
Scully Brian E,
Hirose Toshiharu,
Neu Harold C
Publication year - 1985
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1985.229
Subject(s) - cefixime , pharmacokinetics , cephalosporin , klebsiella pneumoniae , streptococcus pneumoniae , urine , medicine , titer , pharmacology , microbiology and biotechnology , chemistry , antibiotics , escherichia coli , immunology , biology , antibody , biochemistry , gene
The pharmacokinetics of cefixime (FK 027), a broad‐spectrum cephalosporin, were assessed in 12 normal subjects after single oral doses of 50, 100, 200, and 400 mg. Mean peak serum concentrations were 1.02, 1.46, 2.63, and 3.85 µg/ml after the four respective doses. Respective mean serum levels at 12 hours were 0.16, 0.33, 0.72, and 1.13 µg/ml. Volumes of distribution averaged 0.1 L/kg body weight, and the elimination t ½ was 3 hours for all doses. The AUC was 7.01, 11.4, 22.5, and 36.4 µg · hr/ml for the four doses, respectively. Serum clearance averaged 0.4 mg/min/kg and mean 24‐hour urinary recovery was 21%, 19%, 20%, and 16% for the four respective doses. Serum bactericidal titers at 4 hours exceeded 1:16 for Streptococcus pneumoniae, S. pyogenes, Hemophilus influenzae, and Branhamella catarrhalis . Urine bactericidal titers exceeded 1:8 for Escherichia coli, Klebsiella pneumoniae , and Enterobacter cloacae resistant to the available oral cephalosporins. Clinical Pharmacology and Therapeutics (1985) 38, 590–594; doi: 10.1038/clpt.1985.229

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom